206 related articles for article (PubMed ID: 30929368)
21. Laparoscopic surgical technique for left intrahepatic cholangiocarcinoma with lymph node metastasis after conversion therapy (with video).
Wang XR; Cao L; Li JW
Updates Surg; 2023 Aug; 75(5):1351-1353. PubMed ID: 37268764
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center.
Chang ME; Lei HJ; Chen MH; Yeh YC; Li CP; Hung YP; Hsia CY; Liu CA; Chau GY; Chao Y
J Chin Med Assoc; 2017 Mar; 80(3):140-146. PubMed ID: 28169208
[TBL] [Abstract][Full Text] [Related]
23. A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma.
Meng ZW; Lin XQ; Zhu JH; Han SH; Chen YL
J Surg Res; 2018 Jun; 226():56-63. PubMed ID: 29661289
[TBL] [Abstract][Full Text] [Related]
24. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
[TBL] [Abstract][Full Text] [Related]
25. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?
Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR
Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217
[TBL] [Abstract][Full Text] [Related]
26. Predictors, Patterns, and Impact of Adequate Lymphadenectomy in Intrahepatic Cholangiocarcinoma.
Moazzam Z; Alaimo L; Endo Y; Lima HA; Pawlik TM
Ann Surg Oncol; 2023 Apr; 30(4):1966-1977. PubMed ID: 36622527
[TBL] [Abstract][Full Text] [Related]
27. Extent of resection and outcome after curative resection for intrahepatic cholangiocarcinoma.
Kokudo N; Makuuchi M
Surg Oncol Clin N Am; 2002 Oct; 11(4):969-83. PubMed ID: 12607583
[TBL] [Abstract][Full Text] [Related]
28. Lymph node dissection for intrahepatic cholangiocarcinoma: a critical review of the literature to date.
Adachi T; Eguchi S
J Hepatobiliary Pancreat Sci; 2014 Mar; 21(3):162-8. PubMed ID: 24027075
[TBL] [Abstract][Full Text] [Related]
29. The impact of tumor location on the value of lymphadenectomy for intrahepatic cholangiocarcinoma.
Endo Y; Moazzam Z; Lima HA; Alaimo L; Munir MM; Shaikh CF; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Kitago M; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
HPB (Oxford); 2023 Jun; 25(6):650-658. PubMed ID: 36894491
[TBL] [Abstract][Full Text] [Related]
30. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma.
Nakagawa T; Kamiyama T; Kurauchi N; Matsushita M; Nakanishi K; Kamachi H; Kudo T; Todo S
World J Surg; 2005 Jun; 29(6):728-33. PubMed ID: 15880276
[TBL] [Abstract][Full Text] [Related]
31. The clinical value of regional lymphadenectomy for intrahepatic cholangiocarcinoma.
Yang F; Wu C; Bo Z; Xu J; Yi B; Li J; Qiu Y
Asian J Surg; 2022 Jan; 45(1):376-380. PubMed ID: 34340896
[TBL] [Abstract][Full Text] [Related]
32. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.
Miwa S; Miyagawa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Soeda J; Ogawa S
J Gastroenterol; 2006 Sep; 41(9):893-900. PubMed ID: 17048054
[TBL] [Abstract][Full Text] [Related]
33. What prognostic factors are important for resected intrahepatic cholangiocarcinoma?
Paik KY; Jung JC; Heo JS; Choi SH; Choi DW; Kim YI
J Gastroenterol Hepatol; 2008 May; 23(5):766-70. PubMed ID: 17868336
[TBL] [Abstract][Full Text] [Related]
34. [Lymph node metastasis of patients with intrahepatic cholangiocarcinoma].
Chen Z; Yan JJ; Huang L; Wu MC; Yan YQ
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):454-7. PubMed ID: 16772078
[TBL] [Abstract][Full Text] [Related]
35. [Surgical and comprehensive treatment for intrahepatic cholangiocarcinoma patients from the perspective of tumor heterogeneity].
Tang ZH; Quan ZW
Zhonghua Wai Ke Za Zhi; 2018 May; 56(5):328-331. PubMed ID: 29779306
[TBL] [Abstract][Full Text] [Related]
36. Factors influencing the prognosis of patients with intrahepatic cholangiocarcinoma.
Liu ZH; Chen Z; Ma LL; Li XH; Wang LX
Acta Gastroenterol Belg; 2012 Jun; 75(2):215-8. PubMed ID: 22870785
[TBL] [Abstract][Full Text] [Related]
37. Laparoscopic hepatectomy and dissection of lymph nodes for intrahepatic cholangiocarcinoma. Case report.
Harimoto N; Shimada M; Tsujita E; Maehara S; Rikimaru T; Yamashita Y; Maeda T; Tanaka S; Shirabe K; Sugimachi K
Surg Endosc; 2002 Dec; 16(12):1806. PubMed ID: 12239645
[TBL] [Abstract][Full Text] [Related]
38. Intrahepatic cholangiocarcinoma.
Poultsides GA; Zhu AX; Choti MA; Pawlik TM
Surg Clin North Am; 2010 Aug; 90(4):817-37. PubMed ID: 20637950
[TBL] [Abstract][Full Text] [Related]
39. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma.
Tamandl D; Kaczirek K; Gruenberger B; Koelblinger C; Maresch J; Jakesz R; Gruenberger T
Br J Surg; 2009 Aug; 96(8):919-25. PubMed ID: 19591163
[TBL] [Abstract][Full Text] [Related]
40. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S
Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
